12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

GKT137831: Phase Ia data

A Phase Ia trial in 36 healthy volunteers showed that single doses of oral GKT137831 were well tolerated. A Phase...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >